Evidence map›Paper›PMID 37500502›Full record

ArticleGut2024

B and T cell responses to the BNT162b2 COVID-19 mRNA vaccine are not impaired in germ-free or antibiotic-treated mice.

Todd Norton, Miriam Anne Lynn, Charné Rossouw, Arunasingam Abayasingam, Griffith Perkins, Pravin Hissaria, Rowena Anne Bull, David John Lynn

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Gut, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Todd NortonPrecision Medicine, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.
Miriam Anne LynnPrecision Medicine, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.
Charné RossouwPrecision Medicine, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.
Arunasingam AbayasingamThe Viral Immunology Systems Program, The Kirby Institute, Sydney, New South Wales, Australia.
Griffith PerkinsCentral and Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Pravin HissariaAdelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.
Rowena Anne BullThe Viral Immunology Systems Program, The Kirby Institute, Sydney, New South Wales, Australia.
David John LynnPrecision Medicine, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia david.lynn@sahmri.com.ORCID 0000-0003-4664-1404

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BNT162 VaccineCOVID-19COVID-19 VaccinesSARS-CoV-2AnimalsAnti-Bacterial AgentsB-LymphocytesMiceT-LymphocytesAnti-Bacterial AgentsBNT162 VaccineCOVID-19 VaccinesCOVID-19ENTERIC BACTERIAL MICROFLORAIMMUNE RESPONSE

Identifiers

PMID37500502
PMCPMC11185899

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.